Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on September 7, 2023. The filing serves as a Regulation FD disclosure to announce an upcoming Investor Day event scheduled for the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding an investor event rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the scheduling of a corporate event.
Guidance, Outlook, and Management Commentary
Guardant Health will host an Investor Day on September 7, 2023, at 8:00 a.m. Eastern time in New York City. The presentation will feature remarks from co-Chief Executive Officers Helmy Eltoukhy and AmirAli Talasaz, along with other executive management team members. The agenda includes updates on the Company's operations, key strategic priorities, and financial outlook. A live and archived webcast is available on the Company's website.
Investor Verification Checklist
- Verify the date and time of the Investor Day webcast (September 7, 2023, 8:00 a.m. ET).
- Confirm the availability of the live and archived presentation on the "Investors" section of www.guardanthealth.com.
- Note that the information in this 8-K is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
- Review the actual Investor Day presentation materials for specific financial guidance and strategic updates, as they are not contained in this filing.